Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

794214

registered interest
date	23/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mefloquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Earl Howe on 22 November (HL3229), what assessment they have made of the conclusions of the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency in 2014 that: “There is enough evidence … supporting a causal relationship between mefloquine and the occurrence of long lasting and even persistent neuropsychiatric side effects” and a “strong suspicion” that mefloquine can cause “permanent brain damage”.
tabling member printed	The Countess of Mar
uin	HL3532
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>At its meeting in February 2014, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recommended that the product information for mefloquine be amended to state that neuropsychiatric adverse reactions may persist for months, or longer, even after discontinuation of the drug. The PRAC did not recommend that such reactions should be listed as permanent. The United Kingdom product information for mefloquine reflects the final PRAC recommendation.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 05/12/2017 13:55:03 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

794215

registered interest
date	23/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Incinerators: Health Hazards
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government why Public Health England (PHE) commissioned research into possible links between municipal waste incinerators and health outcomes; and why PHE stated that “it is important to stress that PHE's position that well run and regulated modern waste incinerators are not a significant risk to public health remains valid” prior to publication of that research.
tabling member printed	The Countess of Mar
uin	HL3533
answer	answer is ministerial correction date of answer 05/12/2017 answer text <p>Public Health England (PHE) has commissioned a study to extend the evidence base further as to whether emissions from modern municipal waste incinerators affect human health.</p><p> </p><p>From the outset of this study, PHE highlighted that its current position, that well run and regulated modern waste incinerators are not a significant risk to public health, remains valid.</p><p>PHE will review its advice in light of new substantial research on the health effects of incinerators published in peer reviewed journals. To date, PHE is not aware of any evidence that requires a change in their position statement.</p> answering member printed Lord O'Shaughnessy question first answered 05/12/2017 13:49:35 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar